HealthEquity Gross Margin 2014-2024 | HQY

Current and historical gross margin for HealthEquity (HQY) over the last 10 years. The current gross profit margin for HealthEquity as of July 31, 2024 is %.
HealthEquity Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-07-31 $1.10B $0.71B 64.88%
2024-04-30 $1.04B $0.66B 63.37%
2024-01-31 $1.00B $0.62B 62.26%
2023-10-31 $0.97B $0.59B 61.17%
2023-07-31 $0.94B $0.56B 60.02%
2023-04-30 $0.90B $0.53B 58.78%
2023-01-31 $0.86B $0.49B 57.08%
2022-10-31 $0.83B $0.46B 55.60%
2022-07-31 $0.80B $0.44B 55.09%
2022-04-30 $0.78B $0.43B 55.53%
2022-01-31 $0.76B $0.42B 56.08%
2021-10-31 $0.74B $0.42B 56.55%
2021-07-31 $0.74B $0.42B 56.89%
2021-04-30 $0.73B $0.41B 56.53%
2021-01-31 $0.73B $0.42B 56.75%
2020-10-31 $0.75B $0.43B 57.51%
2020-07-31 $0.72B $0.42B 58.01%
2020-04-30 $0.64B $0.38B 59.21%
2020-01-31 $0.53B $0.33B 61.28%
2019-10-31 $0.41B $0.26B 62.90%
2019-07-31 $0.32B $0.21B 64.38%
2019-04-30 $0.30B $0.20B 64.14%
2019-01-31 $0.29B $0.18B 63.07%
2018-10-31 $0.27B $0.17B 62.36%
2018-07-31 $0.26B $0.16B 60.85%
2018-04-30 $0.24B $0.15B 59.84%
2018-01-31 $0.23B $0.14B 59.39%
2017-10-31 $0.22B $0.13B 59.26%
2017-07-31 $0.20B $0.12B 59.41%
2017-04-30 $0.19B $0.11B 59.79%
2017-01-31 $0.18B $0.11B 60.11%
2016-10-31 $0.17B $0.10B 60.48%
2016-07-31 $0.16B $0.09B 60.00%
2016-04-30 $0.14B $0.08B 58.87%
2016-01-31 $0.13B $0.07B 57.48%
2015-10-31 $0.12B $0.07B 58.62%
2015-07-31 $0.11B $0.06B 57.94%
2015-04-30 $0.10B $0.06B 56.12%
2015-01-31 $0.09B $0.05B 54.55%
2014-07-31 $0.06B $0.03B 55.36%
2014-04-30 $0.05B $0.03B 54.00%
Sector Industry Market Cap Revenue
Medical Medical Services $7.792B $1.000B
HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00